Pharma USA 2024

As the healthcare landscape undergoes rapid transformation, the introduction of reforms has paved the way for making medicines more accessible and affordable. Yet, this shift also signals a critical juncture for pharma companies. The effectiveness of traditional commercial models is waning, and the imperative to deliver life-saving treatments to patients is more urgent than ever.

At Syneos Health, we recognize that the key to navigating this evolving terrain lies in embracing commercial excellence and leveraging real-world evidence. While the journey toward innovation and patient-centric solutions is fraught with challenges, it also presents unprecedented opportunities for growth and impact.

Meet with Us

Meet with us at Pharma USA 2024 to discover how we can help you adapt to the changing landscape—and sharpen your short-term strategy for long-term success.  

Speaker Sessions

Related Content

Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below: 

Good Science Is Not Good Enough: For Emerging Companies, Differentiation Requires a Commercial Value Creation Story 

How to Make the Most of Your Non-Core Asset: Partner to Retain Control and Keep Your Options Open 

WEBINAR | The Importance of Early Integrated Evidence Strategy for Cell & Gene Therapies 

Using Real World Evidence for Externally Controlled Trials in Rare Disease Drug Development: Insights from ISPOR Europe 

Mastering New Commercialization Dynamics with an Adaptive Playbook 

WEBINAR | The Three Perils of Cross-Functional Drug Commercialization: Time, Insight and Integration 

Syneos Health Medical Science Liaisons